SARTF (Sartorius AG) Cyclically Adjusted PS Ratio: (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SARTF Sartorius AG SARTF
82 GF Score
Price $212.80
GF Value $274.19
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Sartorius AG Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Sartorius AG  (OTCPK:SARTF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Sartorius AG Cyclically Adjusted PS Ratio Related Terms


Sartorius AG Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Sartorius AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius AG Cyclically Adjusted PS Ratio Chart

Sartorius AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.32 10.52 7.26 4.24 4.30

Sartorius AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.14 3.70 4.30 3.68 0.00

SARTF vs ISRG, BDX, MDLN: Cyclically Adjusted PS Ratio Comparison

For the Medical Instruments & Supplies subindustry, Sartorius AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Cyclically Adjusted PS Ratio falls into.


SARTF
82GF Score
Sartorius AG SARTF
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sartorius AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Sartorius AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Sartorius AG's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=15.143/131.3638*131.3638
=15.143

Current CPI (Jun. 2026) = 131.3638.

Sartorius AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 5.528 101.017 7.189
201612 5.226 101.217 6.783
201703 5.242 101.417 6.790
201706 5.828 102.117 7.497
201709 5.960 102.717 7.622
201712 6.502 102.617 8.323
201803 6.428 102.917 8.205
201806 6.738 104.017 8.509
201809 6.763 104.718 8.484
201812 6.961 104.217 8.774
201903 7.163 104.217 9.029
201906 7.576 105.718 9.414
201909 7.424 106.018 9.199
201912 7.703 105.818 9.563
202003 8.224 105.718 10.219
202006 9.084 106.618 11.192
202009 10.756 105.818 13.353
202012 11.725 105.518 14.597
202103 13.663 107.518 16.693
202106 14.724 108.486 17.829
202109 15.385 109.435 18.468
202112 15.324 110.384 18.237
202203 16.460 113.968 18.972
202206 15.978 115.760 18.132
202209 15.213 118.818 16.819
202212 16.460 119.345 18.118
202303 14.126 122.402 15.160
202306 13.189 123.140 14.070
202309 12.646 124.195 13.376
202312 13.545 123.773 14.376
202403 12.796 125.038 13.443
202406 13.125 125.882 13.697
202409 12.758 126.198 13.280
202412 13.754 127.041 14.222
202503 13.778 127.779 14.165
202506 14.750 128.412 15.089
202509 14.335 129.255 14.569
202512 15.730 129.361 15.974
202603 14.981 131.258 14.993
202606 15.143 131.364 15.143

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Sartorius AG (SARTF) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius AG stock appears to be undervalued. The current stock price of $212.80 is trading 22.4% below its estimated GF Value™ of $274.19. GuruFocus considers Sartorius AG to be Modestly Undervalued.

Key valuation signals for SARTF:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $274.19 vs. price of $212.80 (22.4% below fair value)
  • GF Score™: 82/100 with 10 warning signs

No single metric tells the full story. See the SARTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sartorius AG Business Description

Address Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs and focuses on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.
82GF Score

Get the complete analysis for SARTF

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$212.80
Price
$274.19
GF Value